Cu-II(atsm) improves the neurological phenotype and survival of SOD1(G93A) mice and selectively increases enzymatically active SOD1 in the spinal cord
James B Hilton, Stephen W Mercer, Nastasia KH Lim, Noel G Faux, Gojko Buncic, Joseph S Beckman, Blaine R Roberts, Paul S Donnelly, Anthony R White, Peter J Crouch
SCIENTIFIC REPORTS | NATURE PUBLISHING GROUP | Published : 2017
Related Projects (2)
Awarded by National Health and Medical Research Council
Awarded by DoD Congressionally Directed Medical Research Program
Awarded by Ice Bucket
This work was funded by the National Health and Medical Research Council (Project Grant 1061550 to PJC and PSD; Career Development Fellowship 1084927 to PJC) the University of Melbourne (Research Grant Support Scheme to PJC), and the Motor Neurone Disease Research Institute of Australia (Zo-ee MND Research Grant to PJC and BRR). Part of this work was also supported by funding from the DoD Congressionally Directed Medical Research Program (AL140108 to JSB) and by Ice Bucket donations made to the ALSA (Research Award ALSA 320 to JSB). JBH was recipient of the Australian Postgraduate Award and the Nancy Frances Curry Scholarship. All SOD1<SUP>G93A</SUP> mice and non-transgenic littermates in this study were from The Jackson Laboratory and generously provided by Prize4Life. All ICP-MS analyses were performed by Ms Irene Volitakis at the Biometals Facility, Florey Institute of Neurosciences and Mental Health. Assoc. Prof. Peter Crack kindly provided the Iba-1 antibody.